Form D · Private Equity Fund
Somerset Indus Healthcare India Fund III - Scheme I
Mumbai, K7 · CIK 0002131489
Offering snapshot reported Aug 19, 2026 · SEC filing
- Reported sold
- $25.1M Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2026 | Initial | $25,117,547 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594707
Source: Form D, filed Aug 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Frederick Burgstahler | Director |
| Avinash Kenkare | Director |
| Mayur Sirdesai | Director |
| Somerset Healthcare Investment Advisors Iii Pvt. Ltd. | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
1501, 15 Th Floor, Lodha Supremus Dr Elijah Moses Rd, Worli Naka, Worli
Mumbai, K7, 400018
Mumbai, K7, 400018